KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Q3 2025 value amounting to 0.49.

  • Supernus Pharmaceuticals' Asset Utilization Ratio fell 82.31% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year decrease of 82.31%. This contributed to the annual value of 0.5 for FY2024, which is 2270.75% up from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Asset Utilization Ratio of 0.49 as of Q3 2025, which was down 82.31% from 0.49 recorded in Q2 2025.
  • Supernus Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.49 for Q1 2025, and its period low was 0.36 during Q4 2021.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.41 (2023), whereas its average is 0.43.
  • In the last 5 years, Supernus Pharmaceuticals' Asset Utilization Ratio tumbled by 220.99% in 2022 and then skyrocketed by 2175.35% in 2023.
  • Supernus Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.36 in 2021, then increased by 9.95% to 0.39 in 2022, then increased by 20.64% to 0.47 in 2023, then grew by 2.99% to 0.49 in 2024, then dropped by 0.38% to 0.49 in 2025.
  • Its Asset Utilization Ratio was 0.49 in Q3 2025, compared to 0.49 in Q2 2025 and 0.49 in Q1 2025.